What is ClearPoint Neuro's stock-based comp?

ClearPoint Neuro (CLPT) reported stock-based comp of $2.22M in Q1 2026.

How has ClearPoint Neuro's stock-based comp changed year-over-year?

ClearPoint Neuro's stock-based comp increased by 16.2% year-over-year, from $1.91M to $2.22M.

What is the long-term trend for ClearPoint Neuro's stock-based comp?

Over 4 years (2021 to 2025), ClearPoint Neuro's stock-based comp has grown at a 40.9% compound annual growth rate (CAGR), from $2.08M to $8.18M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

ClearPoint Neuro CLPT Stock-Based Comp

Stock-Based Comp at other companies

AbbottABT

$317M+9.7%

Boston ScientificBSX

$83M+12.2%

IAR

Integra LifeSciencesIART

$5.17M+176%

Zimmer Biomet HoldingsZBH

$24.2M+23.5%

MedtronicMDT

$95M+6.7%

Orthofix Medical Inc.OFIX

$6.53M+1.0%

Other financials

Income statement

See full

Revenue$12.1M+42.9%

Gross profit$7.8M+51.1%

Operating income-$8.5M-37.6%

Net income-$9.6M-58.5%

EPS (diluted)-$0.32-45.5%

Balance sheet

See full

Cash & equivalents$36.5M+195%

Total debt$63.6M+1,750%

Total equity$18.8M-5.7%

Total assets$93.4M+211%

Cash flow

See full

Operating cash flow-$8.0M-29.1%

CapEx$645.0K+252%

Free cash flow-$8.6M-35.5%

Valuation

See full

Market cap$538.61M+69.2%

Enterprise value$565.68M+82.9%

P/S13.3×+3.4×

Profitability

See full

Gross margin62.3%+1.1pp

Operating margin-65.2%-1.9pp

Net margin-71.6%+8.8pp

FCF margin-65.7%+269pp

Returns & leverage

See full

Return on equity-149.7%+4,074pp

Debt / equity3.4×+3.2×

Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ClearPoint Neuro's stock-based comp?: ClearPoint Neuro (CLPT) reported stock-based comp of $2.22M in Q1 2026.
How has ClearPoint Neuro's stock-based comp changed year-over-year?: ClearPoint Neuro's stock-based comp increased by 16.2% year-over-year, from $1.91M to $2.22M.
What is the long-term trend for ClearPoint Neuro's stock-based comp?: Over 4 years (2021 to 2025), ClearPoint Neuro's stock-based comp has grown at a 40.9% compound annual growth rate (CAGR), from $2.08M to $8.18M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.